流动资产 更改
AstraZeneca USD 27.97B 1.65B 2026-06
Bayer EUR 33.64B 1.66B 2026-06
Essilor EUR 11.24B 770M 2026-06
Fresenius EUR 11.61B 456M 2026-06
Fresenius Medical Care EUR 7.69B 418.66M 2026-06
GlaxoSmithKline GBP 17.56B 202M 2026-06
GRIFOLS EUR 5.31B 51M 2026-06
Lonza CHF 8B 3.41B 2025-12
Merck EUR 13.77B 393M 2026-06
Novartis USD 27.35B 744M 2026-06
Philips EUR 9.33B 454M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
Smith & Nephew USD 4.39B 240M 2026-06
Sonova Holding CHF 1.91B 466.3M 2025-06
UCB EUR 6.05B 733M 2025-12